New FDA chief can't come soon enough for beleaguered agency
WASHINGTON (AP) — Straining under a pandemic workload and battered by a string of...
Stay updated with breaking news from Wayne Pines. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WASHINGTON (AP) — Straining under a pandemic workload and battered by a string of...
After nearly nine months of searching, President Joe Biden says he’s close to naming his choice to lead the agency.
Straining under a pandemic workload and battered by a string of public controversies, one of the leading agencies in the government's fight against COVID-19 is finally on the verge of getting a new commissioner.
Straining under a pandemic workload and battered by a string of public controversies, one of the leading agencies in the government's fight against COVID-19 is finally on the verge of getting a new commissioner.
How an Unproven Alzheimerâs Drug Got Approved Though some of its own senior officials said there was little evidence of benefit for patients, the F.D.A. nonetheless greenlighted Biogenâs Aduhelm, or aducanumab. The F.D.A. conducted an internal inquiry this year after allegations were made that the agency was collaborating too closely with Biogen, maker of the Alzheimerâs drug Aduhelm.Credit...Andrew Kelly/Reuters Published July 19, 2021Updated July 20, 2021, 9:29 a.m. ET Two months before the Food and Drug Administrationâs deadline to decide whether to approve Biogenâ...